KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

NCT06747416 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia a and B

Interventions

DRUG: KN057

Sponsor

Suzhou Alphamab Co., Ltd.